Siggi Olafsson to step down as Chief Executive
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma) today announces that Siggi Olafsson has resigned as Chief Executive Officer (CEO), and from Hikma’s Board of Directors, to pursue other opportunities. Said Darwazah, Hikma’s Executive Chairman and former CEO, will assume all CEO responsibilities, enabling Hikma to continue delivering its strategy. Siggi will remain available to […]
Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition
London, England – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Siggi Olafsson, Hikma’s CEO, said: “Hikma continues to make strategic progress, positioning the business for future growth through new product launches, continued investment in R&D, and new strategic partnerships and acquisitions, which are all driving our […]